JW Pharmaceutical shows superiority of 'JW0061' in hair growth over existing treatments in US
JW Pharmaceutical announced the superiority of hair follicle production and hair growth of Wnt-targeted hair loss treatment JW0061” over existing hair loss treatments at the U.S. Society of Investigative Dermatology in Dallas, Texas, from last Wednesday to …